Medibank Private (CHIA:MPL) - Stock Price, News & Analysis

MPL Stock Overview

Provides private health insurance and health services in Australia.

MPL fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	4/6
Past Performance	3/6
Financial Health	5/6
Dividends	2/6

Rewards

Trading at 43.7% below our estimate of its fair value

Earnings are forecast to grow 28.14% per year

Risk Analysis

Dividend of 4.55% is not well covered by earnings

Medibank Private Limited Competitors

nib holdings

ASX:NHF

AU$2.9b

Generation Development Group

ASX:GDG

AU$853.2m

ClearView Wealth

ASX:CVW

AU$361.6m

Steadfast Group

ASX:SDF

AU$6.3b

Price History & Performance

Summary of all time highs, changes and price drops for Medibank Private
Historical stock prices
Current Share Price	AU$3.67
52 Week High	AU$4.01
52 Week Low	AU$3.32
Beta	0.20
11 Month Change	-5.41%
3 Month Change	-0.27%
1 Year Change	7.15%
33 Year Change	3.67%
5 Year Change	11.21%
Change since IPO	70.70%

Recent updates

Shareholder Returns

	MPL	AU Insurance	AU Market
7D	1.2%	-1.4%	0.3%
1Y	7.2%	14.0%	16.1%

Return vs Industry: MPL underperformed the Australian Insurance industry which returned 14% over the past year.

Return vs Market: MPL underperformed the Australian Market which returned 16.1% over the past year.

Price Volatility

Is MPL's price volatile compared to industry and market?
MPL volatility
MPL Average Weekly Movement	2.8%
Insurance Industry Average Movement	3.9%
Market Average Movement	8.9%
10% most volatile stocks in AU Market	17.2%
10% least volatile stocks in AU Market	3.6%

Stable Share Price: MPL has not had significant price volatility in the past 3 months.

Volatility Over Time: MPL's weekly volatility (3%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1976	3,220	David Koczkar	www.medibank.com.au

Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy.

Medibank Private Limited Fundamentals Summary

How do Medibank Private's earnings and revenue compare to its market cap?
MPL fundamental statistics
Market cap	AU$10.08b
Earnings (TTM)	AU$3.90m
Revenue (TTM)	AU$8.03b

2,577x

P/E Ratio

1.3x

P/S Ratio

Is MPL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MPL income statement (TTM)
Revenue	AU$8.03b
Cost of Revenue	AU$6.29b
Gross Profit	AU$1.74b
Other Expenses	AU$1.74b
Earnings	AU$3.90m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.0014
Gross Margin	21.67%
Net Profit Margin	0.049%
Debt/Equity Ratio	1.5%

How did MPL perform over the long term?

See historical performance and comparison

Dividends

4.5%

Current Dividend Yield

11,723%

Payout Ratio

MPL Stock Overview

Rewards

Risk Analysis

Medibank Private Limited Competitors

ASX:NHF

AU$2.9b

ASX:GDG

AU$853.2m

ASX:CVW

AU$361.6m

ASX:SDF

AU$6.3b

Price History & Performance

Recent News & Updates

Medibank Private Limited, Annual General Meeting, Nov 13, 2024

Final dividend of AU$0.094 announced

Medibank Private Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on September 26, 2024

New minor risk - Profit margin trend

High number of new directors

First half dividend increased to AU$0.072

Recent updates

Medibank Private Limited, Annual General Meeting, Nov 13, 2024

Final dividend of AU$0.094 announced

Medibank Private Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on September 26, 2024

New minor risk - Profit margin trend

High number of new directors

First half dividend increased to AU$0.072

First half 2024 earnings released: EPS: AU$0.13 (vs AU$0.061 in 1H 2023)

New major risk - Revenue and earnings growth

Medibank Private Limited to Report First Half, 2024 Results on Feb 22, 2024

Medibank Private Limited Announces Changes to Executive Leadership Team

Anna Bligh to Retire as Non-Executive Director of Medibank Private Limited At the Conclusion its Annual General Meeting on 22 November 2023

Upcoming dividend of AU$0.083 per share at 4.1% yield

Medibank Private Limited Fully Franked Final Ordinary Dividend for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Full year 2023 earnings released: EPS: AU$0.19 (vs AU$0.14 in FY 2022)

Medibank Private Limited Announces Executive Changes, Effective 31 July 2023

Medibank Private Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

First half 2023 earnings released: EPS: AU$0.085 (vs AU$0.08 in 1H 2022)

Medibank Announces Class Action Filed in the Federal Court of Australia

Medibank Private Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Upcoming dividend of AU$0.073 per share

Full year 2022 earnings released: EPS: AU$0.14 (vs AU$0.16 in FY 2021)

Medibank Private Limited Announces Distribution for the Six Months Ended June 30, 2022, Payable on September 29, 2022

Healius Reportedly Launches Day Surgery Sale Process

Medibank Private Limited to Report Fiscal Year 2022 Results on Aug 18, 2022

Independent Non-Executive Director recently bought AU$151k worth of stock

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Medibank Private Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended December 31, 2021, Payable on March 24, 2022

Medibank Private Limited Appoints Kathryn Fagg Ao and Peter Everingham as Non-Executive Directors Effective 31 March 2022

Upcoming dividend of AU$0.069 per share

Full year 2021 earnings released: EPS AU$0.16 (vs AU$0.12 in FY 2020)

Medibank Private Limited Provides Earnings Guidance for 2022

CEO & Director Craig Drummond has left the company

Craig Drummond to Retire as Chief Executive Officer of Medibank Private Limited on 30 June 2021

New 90-day low: AU$2.83

Medibank Private Limited (ASX:MPL) entered into share purchase agreement to acquire 49%stake in Myhealth Medical Holdings Pty Ltd from Crescent Capital Partners Management Pty Ltd and others for AUD 63 million.

Medibank Private Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$3.06

New 90-day high: AU$2.91

New 90-day low - AU$2.49

Independent Non-Executive Director recently bought AU$115k worth of stock

New 90-day low - AU$2.74

Earnings released